Supporting Organization
2 years as a CAC2 member Member since 2025
- Location
- New York, New York
At Syndax, we are advancing the next generation of targeted treatments to realize a future in which people with cancer live longer and better than ever before. We are a commercial stage oncology innovator seeking to develop first-in-class therapies in areas of significant unmet need such as acute leukemia and chronic graft-versus-host disease. Our team is committed to adhering to scientific excellence and dedicated to serving the patient community by delivering therapeutics that provide meaningful and differentiated clinical results and address urgent unmet need.